Translational Medicine is developing in China: A new venue for collaboration

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Wang, Xiangdong ^a   Wang, Ena ^b   Marincola, Francesco M ^b  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; CHINA; EDITORIAL; FINANCIAL MANAGEMENT; INTERDISCIPLINARY COMMUNICATION; MEDICAL SOCIETY; PUBLICATION; QUALITY CONTROL; TRANSLATIONAL MEDICINE; TRANSLATIONAL RESEARCH; COOPERATION; DEVELOPING COUNTRY; HUMAN; INTERPERSONAL COMMUNICATION; LEGAL ASPECT; MEDICINE; METHODOLOGY; PUBLISHING;

CHINA; COMMUNICATION; COOPERATIVE BEHAVIOR; DEVELOPING COUNTRIES; EDITORIAL POLICIES; HUMANS; MEDICINE; PUBLISHING; TRANSLATIONAL RESEARCH;

EID: 78650800311     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-3     Document Type: Editorial

References (27)

1. Marincola FM. Translational medicine: a two way road. J Transl Med 2003, 1:1. 10.1186/1479-5876-1-1, 202357, 14527344.
2. Littman BH, Di Mario L, Plebani M, Marincola FM. What's next in Translational Medicine?. Clin Sci (Lond) 2007, 112:217-227. 10.1042/CS20060108, 17223795.
3. Salgaller ML, Marincola FM. Biotechnology entrepreneurship--where no research has gone before. J Transl Med 2010, 8:102. 10.1186/1479-5876-8-102, 2970591, 20950465.
4. Watson PH, Wilson-McManus JE, Barnes RO, Giesz SC, Png A, Hegele RG, Brinkman JN, Mackenzie IR, Huntsman DG, Junker A, et al. Evolutionary concepts in biobanking - the BC BioLibrary. J Transl Med 2009, 7:95. 10.1186/1479-5876-7-95, 2785772, 19909513.
5. Szalma S, Koka V, Khasanova T, Perakslis ED. Effective knowledge management in translational medicine. J Transl Med 2010, 8:68. 10.1186/1479-5876-8-68, 2914663, 20642836.
6. Sino-American Symposium on Clinical and Translational Research. 2010, , http://www.chinacts.org
7. Ferte C, Andre F, Soria JC. Molecular circuits of solid tumors: prognostic and predictive tools for bedside use. Nat Rev Clin Oncol 2010, 7:367-380. 10.1038/nrclinonc.2010.84, 20551944.
8. Ascierto PA, Streicher HZ, Sznol M. Melanoma: a model for testing new agents in combination therapies. J Transl Med 2010, 8:38. 10.1186/1479-5876-8-38, 2873374, 20406483.
9. Symposium on Advanced Biotechnologies & Instrumentations. 2010, , http://www.sabish.org
10. China Medical Zones Provide Opportunities. 2010, , http://rightsite.asia/en/article/china-medical-zones-provide-opportunities
11. Beijing Lishen Cardiovascular Health Foundation. 2010, , http://www.bjlshf.org
12. Tang Foundations. 2010, , http://www.tangfoundation.org
13. International Society for Translational Medicine. 2010, , http://www.stmed.org
14. Mankoff SP, Brander C, Ferrone S, Marincola FM. Lost in translation: obstacles to Translational Medicine. J Transl Med 2004, 2:14. 10.1186/1479-5876-2-14, 420261, 15149545.
15. Nussenblatt RB, Marincola FM, Schechter AN. Translational medicine--doing it backwards. J Transl Med 2010, 8:12. 10.1186/1479-5876-8-12, 2831830, 20132543.
16. Nussenblatt RB, Meinert CL. The status of clinical trials: cause for concern. J Transl Med 2010, 8:65. 10.1186/1479-5876-8-65, 2907327, 20609234.
17. Drug Discovery World. 2010, , http://www.ddw-online.com
18. Romero P, Fox BA. Announcing the tumor immunology and biological cancer therapy section (edited by iSBTc) of the Journal of Translational Medicine. J Transl Med 2009, 7:80. 10.1186/1479-5876-7-80, 2753320, 19761590.
19. Vidal-Vanaclocha F, Witz IP. Introducing the cancer microenvironment section of Journal of Translational Medicine. J Transl Med 2010, 8:60. 10.1186/1479-5876-8-60, 2904727, 20569469.
20. Stroncek DF, Puri RK. Cell and gene therapies: moving from research to clinic. J Transl Med 2010, 8:31. 10.1186/1479-5876-8-31, 2859382, 20350323.
21. Mintzberg H. Organizational design, fashion or fit?. Harvard Business Rev 1981, 59:103-116.
22. Ablin RJ, Marincola FM, Natali PG. The Excellence in Translational Medicine and Bedside-to-Bench Awards 2008-09. J Transl Med 2010, 8:95. 10.1186/1479-5876-8-95, 2964610, 20942919.
23. Van EL, Marincola FM, Strohm J. Bridging the divide between science and journalism. J Transl Med 2010, 8:25. 10.1186/1479-5876-8-25, 2847545, 20219123.
24. Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, et al. A systematic approach to biomarker discovery; Preamble to the iSBTc-FDA taskforce on Immunotherapy Biomarkers. J Transl Med 2008, 6:81. 10.1186/1479-5876-6-81, 2630944, 19105846.
25. Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, et al. Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology. J Transl Med 2009, 7:45. 10.1186/1479-5876-7-45, 2724494, 19534815.
26. Butterfield LH, Disis ML, Khleif SN, Balwit JM, Marincola FM. Immuno-Oncology Biomarkers 2010 and Beyond: Perspectives from the iSBTc/SITC Biomarker Task Force. J Transl Med 2010, 8:130. 10.1186/1479-5876-8-130, 3014892, 21138581.
27. International Conference on Translational Medicine 2011. 2010, , http://www.stmed.org/?mt/MjY=/SUNUTTIwMTE=